@xconomy.com 22 days ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 8 months ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal